Differences in Prognosis Based on Timing of Anti-VEGF Therapy loading dose in Retinal Vein Occlusion: A Multicenter, Retrospective, Observational Study

Differences in Prognosis Based on Timing of Anti-Vascular endothelial growth factor Therapy loading dose in Retinal Vein Occlusion: A Multicenter, Retrospective, Observational Study - Anti-VEGF Therapy in Retinal Vascular Occlusion: A Retrospective Observational Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060789

Enrollment

300

Registered

2026-03-31

Start date

2026-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Vein Occlusion

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with retinal vein occlusion (RVO) 2) RVO cases seen since 2020 3) Cases followed for one year 4) Cases aged 20 years or older

Exclusion criteria

Exclusion criteria: 1) Cases under 20 years of age 2) Cases already treated with anti-VEGF agents, laser therapy, or surgery 3) Patients deemed unsuitable as research subjects by the principal investigator or co-investigator

Design outcomes

Primary

Measure	Time frame
One-year visual acuity improvement rate	—

Secondary

Measure	Time frame
Improvement in foveal retinal thickness over one year Number of treatments over one year	—

Countries

Japan

Contacts

Public ContactHidetaka Noma

Tokyo Medical University Ibaraki Medical Center Ophthalmology

noma-hide@umin.ac.jp0298871611

Outcome results